Drug Profile
Research programme: oncolytic virus therapies - Immusol/Baylor College of Medicine
Alternative Names: Anticancer virus therapies - Immusol; Oncolytic herpes simplex virus therapies - ImmusolLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Baylor College of Medicine
- Class Oncolytic viruses
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Solid-tumours in USA
- 01 Feb 2006 Preclinical trials in Solid tumours in USA (unspecified route)